港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

生物医药B类股

492.301

-8.510-1.70%

涨家数：3

跌家数：27

平家数：3

市盈率：- -

高：501.068

开：501.068

低：481.557

收：500.811

成交量：7,406.45万

成交额：19.55亿

市值：3,109.35亿

流通市值：2,788.25亿

数据加载中...

总览新闻资讯

创新药出海之后，CXO能否接住订单复苏？

医药板块重估进入下半场：谁还能继续享受出海溢价？

从首付款到销售分成：创新药BD如何真正改写企业估值

2只大赚超110%！前三季度主动权益基金业绩放榜

百诺医药终止北交所IPO 原拟募资8亿元中信建投保荐

BD密集落地，创新药重估从管线想象走向业绩验证

科济药业-B(02171)：郭华清辞任非执行董事

创胜集团医药-B(06628)根据股份激励计划授出 3万股新的奖励股份

医药板块分化加剧，创新药龙头迎来BD第二增长曲线

华尔街见闻

PMI重返扩张区间，农副食品加工、医药等行业产需活跃，分析师：未来3到5年创新药及CDMO将迎来持续高景气度周期，并保持较快增长

每日经济新闻

康希诺生物(06185)A股股票交易异常波动不存在应披露而未披露重大信息

公募基金四季度策略曝光：“科技+红利”哑铃策略成共识

东方财富网

A股震荡盘整！购房贴息重磅落地，地产股批量拉升！医药全天领跑，港股通医疗ETF（159137）标的指数上探4%

医药全天领跑！巨头密集加码AI制药，翻倍牛股叒新高！港股通医疗ETF（159137）创阶段新高，标的指数上探4%

迪哲医药收到阿斯利康全球授权首付款6亿美元

经济参考网

港股通腾讯净流入14.07亿港元

阿斯达克财经

德琪医药-B(06996)9月30日斥资30.45万港元回购8.8万股

创新药一路狂涨！688185，直线20cm涨停

东方财富网

节前收红！这个强势板块节后能否继续上涨？

节前最后一天，医药股大爆发

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/BK1574/news?page=9"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物医药B类股","latestPrice":492.301,"timestamp":1791878906339,"preClose":500.8114,"halted":0,"volume":74064459,"delay":0,"changeRate":-0.016993,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-8.510406,"latestTime":"10-13 16:00:00","open":501.06766,"high":501.06766,"low":481.5568,"amount":1955398739.5,"amplitude":0.038959,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791941400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1791855000000,1791864000000],[1791867600000,1791878400000]],"pbRate":3.724844,"peRate":165.446177,"turnoverRate":0.002775,"increases":3,"decrements":26,"flats":3,"marketCap":310934550112,"floatMarketCap":278824693896},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":501.06766,"amplitude":0.038959,"preClose":500.8114,"low":481.5568,"pbRate":"3.724844","latestPrice":492.301,"volume":74064459,"delay":0,"open":501.06766,"prevYearClose":556.26263,"prevWeekClose":503.547,"prevMonthClose":532.388,"prevQuarterClose":532.388,"fiveDayClose":534.856,"twentyDayClose":502.512,"sixtyDayClose":494.234,"secType":"PLATE","market":"HK","turnoverRate":0.002775,"peRate":165.446177,"marketCap":310934550112,"floatMarketCap":278824693896,"timestamp":1791878906339,"nameCN":"生物医药B类股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":3,"down":27,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672758061","title":"创新药出海之后，CXO能否接住订单复苏？","url":"https://stock-news.laohu8.com/highlight/detail?id=2672758061","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672758061?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 16:18","pubTimestamp":1790842680,"startTime":"0","endTime":"0","summary":"9月医药板块的重估，起点是创新药出海交易的密集落地，真正决定行情能否继续的，却是一个更具体的问题：BD交易能否转化为CXO产业链的订单、收入和利润？公开资料显示，国家药监局9月14日披 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261001/c680429674.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261001/c680429674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["CXO","MEDX","06978","BK1574","LNGR","159992","BK1161","WX","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672709758","title":"医药板块重估进入下半场：谁还能继续享受出海溢价？","url":"https://stock-news.laohu8.com/highlight/detail?id=2672709758","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672709758?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 16:18","pubTimestamp":1790842680,"startTime":"0","endTime":"0","summary":"9月医药板块的上涨，表面看是创新药BD交易密集落地，深层则是资金再平衡与产业预期修复同时发生。问题也随之变得更具体：创新药出海加速，能否把医药板块从一轮估值修复，推向持续的业绩重 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261001/c680429672.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261001/c680429672.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK1161","09939","159938","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672538797","title":"从首付款到销售分成：创新药BD如何真正改写企业估值","url":"https://stock-news.laohu8.com/highlight/detail?id=2672538797","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672538797?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 16:18","pubTimestamp":1790842680,"startTime":"0","endTime":"0","summary":"创新药出海正在成为医药板块重新定价的重要线索，但市场真正需要回答的问题是：一纸高额License-out合同，究竟有多少已经兑现，多少仍停留在远期预期？9月以来，创新药板块的交易热度明显抬 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261001/c680429673.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261001/c680429673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["MEDX","BUYO","IBBQ","BK1574","06978","LQPE","BK1161","LNGR","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672734922","title":"2只大赚超110%！前三季度主动权益基金业绩放榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2672734922","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672734922?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 12:47","pubTimestamp":1790830020,"startTime":"0","endTime":"0","summary":"进入第三季度，市场回调力度进一步放大。其中，易方达供给改革以115.67%的收益率拿下前三季度主动权益基金冠军，易方达产业机遇以111.62%紧随其后位列第二。今年三季度单季主动权益基金涨幅前10名当中，有9只属于医药医疗主题。截至9月30日，前三季度跌幅榜前30名的主动权益基金跌幅全部超过36%，制造升级、低碳经济、新能源、部分科技方向成为“重灾区”，科技成长赛道内部出现极端分化行情。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-10-01/doc-initsyai2060750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ARTY","BK1161","09939","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672391187","title":"百诺医药终止北交所IPO 原拟募资8亿元中信建投保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2672391187","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672391187?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 11:05","pubTimestamp":1790823904,"startTime":"0","endTime":"0","summary":"中国经济网北京10月1日讯 北交所网站9月30日披露关于终止对山东百诺医药股份有限公司 公开发行股票并在北京证券交易所上市审核的决定。　　北交所于2025年9月18日受理了百诺医药提交的公开发行相关申请文件，并按照规定进行了审核。　　百诺医药原拟向不特定合格投资者公开发行股票不超过26,495,492股。　　百诺医药本次的保荐机构为中信建投证券股份有限公司，保荐代表人为杨鑫、赵之翼。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202610/01/20261001756250.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202610/01/20261001756250.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20261001/32386448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["KCE","FRHC","159938","BK0276","09939","REDS","BK1515","BK1574","BK1161","BK4127","IPOS","601066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672786121","title":"BD密集落地，创新药重估从管线想象走向业绩验证","url":"https://stock-news.laohu8.com/highlight/detail?id=2672786121","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672786121?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 00:18","pubTimestamp":1790785080,"startTime":"0","endTime":"0","summary":"9月30日，国庆假期前的最后一个交易日，医药板块成为A股最强方向之一。医药指数收涨2.73%，创新药指数上涨3.42%，超过400只医药成分股收红。康希诺开盘后约9分钟封住20厘米涨停，收盘报102. ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261001/c680424914.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261001/c680424914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LNGR","IBBQ","MEDX","06978","BK1161","BK1574","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671202752","title":"科济药业-B(02171)：郭华清辞任非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2671202752","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671202752?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 21:04","pubTimestamp":1790773461,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科济药业-B(02171)发布公告，由于需要投放更多时间于其他个人业务，郭华清先生(郭先生)已提出辞任本公司非执行董事，自2026年9月30日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502921.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"科济药业-B(02171)：郭华清辞任非执行董事","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1587","BK1585","02171","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671202294","title":"创胜集团医药-B(06628)根据股份激励计划授出 3万股新的奖励股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2671202294","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671202294?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 21:02","pubTimestamp":1790773371,"startTime":"0","endTime":"0","summary":"智通财经APP讯，创胜集团医药-B(06628)发布公告，于2026年9月30日，为替代已取消的先前授出，本公司根据股份激励计划授出 3万股新的奖励股份(新奖励股份)予程根宏教授(程教授)(授出)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502918.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06628","BK1515","09939","159938","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671120719","title":"医药板块分化加剧，创新药龙头迎来BD第二增长曲线","url":"https://stock-news.laohu8.com/highlight/detail?id=2671120719","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671120719?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 20:27","pubTimestamp":1790771252,"startTime":"0","endTime":"0","summary":"汇丰前海认为，中国医药板块正因创新药占比不同加速分化：恒瑞、翰森等创新药龙头未来两年产品收入增速有望达到10%至15%，而其他药企增长相对有限。与此同时，海外授权资产全球三期进展及BD里程碑收入，正成为2027至2028年新的增长与估值驱动。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3782839","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1161","159938","MEDX","06978","BK1515","LNGR","BK1574","159992","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671204520","title":"PMI重返扩张区间，农副食品加工、医药等行业产需活跃，分析师：未来3到5年创新药及CDMO将迎来持续高景气度周期，并保持较快增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2671204520","media":"每日经济新闻","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671204520?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 20:18","pubTimestamp":1790770720,"startTime":"0","endTime":"0","summary":"9月30日，国家统计局公布9月PMI（采购经理指数）数据。9月份，制造业采购经理指数、非制造业商务活动指数和综合PMI产出指数分别为50.1%、50.2%和50.7%，比上月上升0.3个、1.2个和1.2个百分点，经济景气水平有所回升。图片来源：国家医保局从行业看，农副食品加工、医药等行业生产指数和新订单指数均高于55.0%，相关企业产需释放较快。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609303887863678.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609303887863678.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["MEDX","BK1574","FXR","LNGR","09939","BK4139","159992","159938","06978","CDMO","VAW","IBBQ","IYJ","RSPM","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671058209","title":"康希诺生物(06185)A股股票交易异常波动 不存在应披露而未披露重大信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2671058209","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671058209?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 19:51","pubTimestamp":1790769105,"startTime":"0","endTime":"0","summary":"公司关注到近期市场上关于 mRNA 技术的发展，海外mRNA肿瘤疫苗临床阶段性数据发布或计划公开。mRNA 平台是公司布局的技术平台之一，公司正在进行 mRNA 预防用疫苗及治疗性生物制品的开发，以及相关递送系统的开发。公司董事、高级管理人员、控股股东及其一致行动人在公司本次股票交易异常波动期间不存在买卖公司股票的情况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502875.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["82823","399300","83130","82846","07233","02846","83188","82843","BK1574","03188","BK1161","159982","02822","BK1515","06185","BK1610","03130","BK1147","02827","BK1191","82822","02823","02843"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671018012","title":"公募基金四季度策略曝光：“科技+红利”哑铃策略成共识","url":"https://stock-news.laohu8.com/highlight/detail?id=2671018012","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671018012?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 19:22","pubTimestamp":1790767342,"startTime":"0","endTime":"0","summary":"进入四季度，公募基金如何布局？近期，国泰基金、平安基金、财通资管、南方基金、长城基金、前海开源基金、国海富兰克林基金、上银基金等多家公募机构陆续发布四季度A股投资策略和观点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/1405,202609303887850054.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/1405,202609303887850054.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["LNGR","VGT","VTHR","CHAT","BK4585","BK1161","AIPO","BK4588","IBBQ","QTOC","ARTY","MEDX","BK1574","AGIX","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671062192","title":"A股震荡盘整！购房贴息重磅落地，地产股批量拉升！医药全天领跑，港股通医疗ETF（159137）标的指数上探4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671062192","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671062192?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 19:05","pubTimestamp":1790766300,"startTime":"0","endTime":"0","summary":"港股方面，港股医药高弹进攻，港股通创新药ETF华宝、港股通医疗ETF华宝标的指数盘中最高涨幅均超4%。港股通医疗ETF创阶段新高，标的指数上探4%9月最后一日，A+H医药联袂大涨收官！A股医药生物领跑全行业，场内热门医疗ETF华宝、药ETF华宝标的指数分别大涨2.82、2.68%。可关注两个T+0交易工具：港股通医疗ETF华宝：标的指数AI制药含量近70%，CXO含量超50%。布局央国企及优质房企，建议重点关注地产ETF华宝。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-30/doc-initrfsz5755568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09939","159828","399300","159938","82823","02843","02822","159982","BK1610","02823","BK1574","82822","82843","BK1515","159137","82846","02827","83130","07233","BK1147","03188","BK1161","83188","FLHK","02846","03130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671206990","title":"医药全天领跑！巨头密集加码AI制药，翻倍牛股叒新高！港股通医疗ETF（159137）创阶段新高，标的指数上探4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671206990","media":"新浪基金","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671206990?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 19:03","pubTimestamp":1790766180,"startTime":"0","endTime":"0","summary":"A股医药生物领跑全行业，场内热门医疗ETF华宝、药ETF华宝标的指数分别大涨2.82、2.68%。港股医药高弹进攻，港股通创新药ETF华宝、港股通医疗ETF华宝标的指数盘中最高涨幅均超4%，双双收涨近3.8%，其中159137交易所收盘价创6个月新高！图：港股通医疗ETF华宝近6月走势盘面上，AI制药重回主线，纯正标的及产业链上游CXO强势领涨！可关注两个T+0交易工具：港股通医疗ETF华宝：标的指数AI制药含量近70%，CXO含量超50%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-30/doc-initrfsz1985877.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159137","ARTY","QTOC","VTHR","01477","159938","BK1574","09939","FLHK","AGIX","BK1161","BK1191","159828","BK1515","AIPO","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671677205","title":"迪哲医药收到阿斯利康全球授权首付款6亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671677205","media":"经济参考网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671677205?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 18:34","pubTimestamp":1790764463,"startTime":"0","endTime":"0","summary":"9月29日晚，迪哲医药（688192.SH）公告称，公司已于近期收到阿斯利康就舒沃哲（舒沃替尼）全球授权支付的6亿美元首付款。该笔款项的到账，标志着这款由迪哲医药自主研发的口服EGFR抑制剂全球商业化进程进入实质阶段。根据公告，迪哲医药此前与阿斯利康签署《许可协议》，授予阿斯利康在全球范围内独家开发、商业化舒沃哲的权利。协议于2026年8月31日正式生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609303887811076.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609303887811076.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","09939","BK1574","159938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671203083","title":"港股通腾讯净流入14.07亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671203083","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671203083?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 18:25","pubTimestamp":1790763900,"startTime":"0","endTime":"0","summary":"北水南向净流入腾讯 、药明生物及MINIMAX-W，分别达14.07亿港元、1.79亿港元及1.67亿港元。北水南向净流出中芯、智谱及康方生物，分别达9.71亿港元、1.46亿港元及1,716万港元。港股通(深)最高资金净流入活跃股份为腾讯6.84亿港元，而最高资金净流出股份为中芯8.09亿港元。全日南向合计净流出0港元，总成交额为699.27亿元，占大市成交额37.36%。(港股报价延迟最少十五分钟。沽空资料截至 2026-09-30 16:25。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190218172325341_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190218172325341_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1547310/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1547310/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU1242518931.SGD","LU0132412106.USD","LU0819123356.HKD","IE00BGV7N243.SGD","BK1618","LU0164880469.USD","BK1607","LU2097828474.EUR","HK0001040168.HKD","LU0048388663.USD","LU0828238088.HKD","LU2237443978.SGD","LU2498475776.HKD","HK0000151867.HKD","LU0708995583.HKD","LU0345776255.USD","LU0054237671.USD","LU1481107354.HKD","LU2152927971.USD","LU0188438112.USD","IE00BZ08YS42.EUR","LU1196710351.USD","HK0000306685.HKD","LU0463099449.HKD","LU0345769631.USD","IE0009570106.USD","IE0031814852.USD","LU0128522157.USD","LU0823413587.USD","LU0047713382.USD","LU1785774172.SGD","LU0784639295.USD","LU0878004406.USD","SG9999001846.SGD","JEMA","LU1242518857.USD","LU0972618739.USD","LU0117844026.USD","LU0259732245.USD","LU0594300419.USD","LU2399975544.HKD","LU0229945570.USD","LU0128526141.USD","LU0878005551.USD","LU0417516738.SGD","LU0449509016.USD","SGXZ81514606.USD","LU1733274473.HKD","LU0348783233.USD","LU1719994722.HKD","LU0173614495.USD","LU0314109678.HKD","LU1235295612.USD","LU0823426308.USD","GAMR","LU0359201885.HKD","LU2106854487.HKD","LU0149534421.HKD","LU1282651048.USD","LU2476274720.SGD","LU0348788117.USD","IE00B3M56506.USD","LU0214875030.USD","LU0588545490.SGD","LU2039709279.SGD","XSOE","BK1576","HK0001040143.USD","LU1044874839.SGD","LU0080751232.USD","LU1675838814.USD","LU0228367735.SGD","LU1439103000.SGD","LU0052750758.USD","LU0651946864.USD","SG9999014674.SGD","FDNI","LU1188198961.HKD","LU0577902298.EUR","LU0856984785.SGD","HK0000352382.USD","LU0608807433.USD","LU0862451837.USD","SG9999001226.SGD","SG9999015945.SGD","IE00B5MMRT66.SGD","LU0143863784.USD","LU2097828714.EUR","SG9999001069.SGD","LU0196878994.USD","SG9999000418.SGD","LU0797268264.HKD","LU0203345920.USD","LU1226287792.SGD","LU0531971595.HKD","LU0865486749.SGD","IE0034224299.USD","LU2087589342.USD","LU1048588211.SGD","LU0531970944.HKD","LU1880383366.USD","LU0348767384.USD","LU0169518387.USD","HK0000288784.HKD","LU0791591158.USD","LU0048580855.USD","HK0000306701.USD","IE0003851619.USD","LU1282649067.USD","LU0651947912.USD","LU2226246903.HKD","LU1814569148.SGD","BK1095","LU0543330483.HKD","SG9999014898.SGD","BK1531","LU2237443382.USD","LU0456827905.SGD","LU0831103253.SGD","LU0890818403.SGD","EEMX","LU0048597586.USD","LU0417516571.SGD","LU2294711473.HKD","BK1589","LU0700851271.USD","LU0096374516.USD","LU0819121731.USD","LU1226287529.USD","LU1868838027.USD","LU0011963245.USD","LU0181495838.USD","GB00BDT5M118.USD","LDEM","LU0608807946.USD","BK1117","BK1526","LU1718418525.SGD","LU2133065610.SGD","LU0862451753.SGD","LU1868837565.USD","LU0791590937.USD","LU1152091168.USD","SG9999014914.USD","IE0008368411.USD","LU0029874061.USD","LU0918141887.USD","LU1917777945.USD","LU0140636845.USD","LU0456846285.SGD","LU0708995153.HKD","LU1303224171.USD","LU0449515922.USD","CXSE","ODDS","LU2237443549.SGD","SG9999018857.SGD","LU0211977185.USD","BIDD","WXXWY","SG9999003461.SGD","LU0070217475.USD","LU0269904917.USD","LU0289960550.SGD","LU0516422952.EUR","LU2265009873.SGD","LU0165289439.USD","00100","EMC","LU1282651121.HKD","LU2051468812.USD","LU0823397103.USD","IE0003895053.USD","LU1064131003.USD","LU0029875118.USD","LU0149721374.USD","LU0210526637.USD","LU0823426480.USD","LU0588546209.SGD","LU0072913022.USD","LU0823038988.USD","BK1502","LU0594300179.USD","SG9999006597.SGD","LU0231483743.USD","LU1956131251.USD","LU2449936058.SGD","SG9999004220.SGD","LU0979878070.USD","LU1794554557.SGD","LU1808992512.USD","LU0516422366.SGD","LU0588545904.SGD","IE00B0169N27.USD","LU1515016050.SGD","SG9999013353.USD","LU1211504680.USD","SG9999002463.SGD","LU0143863198.USD","SGXZ31699556.SGD","BK1615","IE00B97KM107.HKD","LU0307460666.USD","LU2279858448.HKD","LU0117841782.USD","HK0000320264.USD","LU0882747503.HKD","LU2251237306.USD","LU1807302812.USD","LU1981816686.USD","LU0370786039.SGD","LU0163747925.USD","SG9999015952.SGD","SG9999015978.USD","BK1614","LU0642271901.SGD","LU0043850808.USD","BK1517","LU0329678337.USD","IE00BQXX3F31.USD","LU0633140727.USD","LU2279701549.SGD","TCHI","LU0823039010.USD","LU1770036033.HKD","LU0516423091.SGD","BK1521","LU0251144936.SGD","SGXZ51526630.SGD","LU0164865239.USD","LU0211331839.USD","LU0868486357.SGD","LU1880383440.USD","LU1224709979.USD","IE00B29SXG58.USD","LU1688375341.USD","TCEHY","SG9999001093.SGD","LU0348825331.USD","LU0572940350.SGD","LU0828237510.HKD","LU1629966141.USD","LU1328615791.USD","LU1206782309.USD","LU0287142896.SGD","LU0683595622.HKD","JADE","LU0396098781.USD","LU0561508036.HKD","LU0320764243.SGD","LU1102505762.USD","LU1504937902.USD","IE00B8HQ1Z84.USD","BKF","LU0293314216.USD","IE00B0169L03.USD","BK1610","HK0000288743.USD","LU0577902538.SGD","LU0737861772.HKD","LU0348827113.USD","LU0675040207.SGD","SG9999017495.SGD","IE0032834883.USD","LU0029874905.USD","LU0417516902.SGD","IE0032431581.USD","LU0329678170.USD","LU1102505929.USD","SG9999000459.SGD","LU0572944931.SGD","LU0348766576.USD","LU3063872942.SGD","LU0348805143.USD","BK1141","LU0648948544.HKD","SG9999006514.SGD","LU0828237940.HKD","LU1810669033.SGD","IE00B8L5B284.USD","IE00BPRC5H50.USD","BK1591","LU1734074674.USD","LU1974910355.USD","LU0640798160.USD","LU0541501648.USD","LU0634319403.HKD","LU1366334578.USD","LU0054450605.USD","LU2008162690.USD","HK0000914660.USD","LU1568876335.HKD","LU1323998911.USD","LU1568876251.USD","LU1171460220.USD","LU1105468828.SGD","LU1282648689.USD","LU0455707207.USD","LU1051769294.HKD","SG9999007991.SGD","BK1163","LU0244354667.USD","LU0441854154.USD","FFEM","LU1868837722.USD","LU0588545730.USD","BK1516","LU0320764755.SGD","LU0107464264.USD","LU0106259558.USD","IE0008369823.USD","LU1226287875.USD","LU0611395673.USD","SG9999015986.USD","LU1064130708.USD","LU2125910849.SGD","LU1961090484.USD","LU0348816934.USD","IE00BQXX3D17.EUR","LU0315178854.USD","LU1196710864.SGD","IE0003795394.USD","LU1883866441.USD","LU2237443465.HKD","LU0328353924.USD","LU0345775950.USD","LU0128522744.USD","LU2488822045.USD","SG9999001689.USD","LU0650527681.SGD","IE00BQXX3C00.GBP","IE00B031HW06.USD","LU0072462343.USD","LU0633140560.USD","LU0348783662.USD","BK1609","LU0593848301.USD","LU1226288170.HKD","LU1655091459.SGD","LU1008478684.HKD","LU1115378108.SGD","SG9999001903.USD","LU0051755006.USD","LU0502904849.HKD","IE0001KFT4U8.USD","LU0541502299.USD","LU0469268626.HKD","LU0499858602.USD","SG9999018865.SGD","LU1044876610.USD","LU0589944569.HKD","LU0203347892.USD","LU0049112450.USD","KURE","LU0127658192.USD","LU0326950275.SGD","LU0577902611.USD","LU0501845795.SGD","LU1813983027.USD","LU0886674414.USD","LU2177674079.SGD","LU0873338254.USD","KWEB","LU0164872284.USD","IE00B031HY20.USD","SG9999002828.SGD","LU0315179316.USD","LU1366334651.USD","BK1161","LU1642822792.SGD","LU0235996351.USD","688981","LU1439102457.SGD","LU3227948356.SGD","IE00BZ08YT58.USD","LU0572939691.SGD","LU0039217434.USD","IE00B543WZ88.USD","HK0000320223.HKD","LU0540923850.HKD","LU0823413660.USD","LU0261950983.USD","LU0348735423.USD","LU0320764599.SGD","LU0261947096.USD","09926","LU0509642566.USD","LU1993786604.SGD","LU1282649141.HKD","LU2125910500.SGD","LU2242644610.SGD","LU0192582467.USD","IE00B0JY6N72.USD","LU1048596156.SGD","02513","LU0348784397.USD","BK1608","LU1048484197.HKD","LU0577902371.SGD","LU0228659784.USD","LU1691799644.USD","LU2097828631.EUR","SGXZ99366536.SGD","IE00B031J352.USD","SGXZ90724238.SGD","LU1251922891.USD","LU0488056044.USD","LU1769817096.USD","HTCD.SI","LU0348814723.USD","LU0210527791.USD","LU1831875114.USD","SG9999000327.SGD","LU0898667661.SGD","SG9999001051.SGD","SG9999014906.USD","LU1226288097.SGD","LU1769817179.HKD","LU1725190679.HKD","LU0577902454.USD","LU1960683339.HKD","LU0327786744.USD","LU0821914370.USD","LU0049853897.USD","LU0738912210.USD","LU0067412154.USD","LU0414403682.SGD","LU2237443895.HKD","LU0823041008.USD","SG9999002562.SGD","LU0175139822.USD","LU0254981946.USD","LU0823397285.USD","LU1224444064.USD","LU1733274390.USD","BK1574","LU2362540622.SGD","LU1316542783.SGD","LU2148510915.USD","SOCL","LU0359201612.USD","LU1152091754.HKD","LU0918141705.HKD","LU1804176565.USD","LU2097828805.USD","LU1023057109.AUD","LU0985320562.USD","LU2045819591.USD","LU0672654166.SGD","IE00B067MR52.USD","LU0607220059.USD","HK0000914686.HKD","LU2251237488.HKD","LU2362541273.HKD","BK1586","LU0106959298.USD","LU1282649810.SGD","LU2237443622.USD","IE0008368742.USD","LU2317271919.USD","02269","LU0871576103.HKD","LU0605514214.HKD","LU0543330566.HKD","LU0786609619.USD","LU0106252389.USD","LU2247934214.USD","LU0061477393.USD","LU0210533765.USD","LU0499858438.USD","HK0000352291.HKD","LU1046422090.SGD","LU1044875133.USD","LU0264606111.USD","LU0326948709.USD","LU1328277881.USD","LU1051768304.USD","IE00BZ08YR35.GBP","LU0431992006.USD","LU0823040885.USD","LU2362541513.USD","00700","ESPO","LU0456842615.SGD","LU2293587155.HKD","LU2778985437.USD","LU2097828557.USD","LU2476274308.USD","LU0880133367.SGD","LU1196710195.USD","LU1951186391.HKD","LU1770034418.SGD","LU0737861699.HKD","LU0084288322.USD","LU1720050803.USD","LU0348723411.USD","LU1226288253.USD","LU0516423174.USD","EMCS","LU2462611646.USD","LU0516422440.USD","LU0359202008.SGD","LU2257852520.SGD","LU0384037296.USD","LU0345769128.USD","LU2023250504.SGD","IE00BF5LJ272.USD","00981","SG9999014880.SGD","AAXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671180203","title":"德琪医药-B(06996)9月30日斥资30.45万港元回购8.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2671180203","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671180203?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 18:23","pubTimestamp":1790763821,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德琪医药-B(06996)发布公告，于2026年9月30日斥资30.45万港元回购8.8万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502755.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06996","BK1574","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671057522","title":"创新药一路狂涨！688185，直线20cm涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2671057522","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671057522?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 18:23","pubTimestamp":1790763780,"startTime":"0","endTime":"0","summary":"9日最后一个交易日，A股三大指数今日涨跌不一，截至收盘，上证指数涨0.31%，深证成指跌0.11%，创业板指跌0.23%，北证50涨0.7%，科创50指数跌2.51%。全市场成交额14500亿元，较上日放量285亿元，全市场超2800只个股下跌。创新药板块涨幅第一，康希诺触及20cm涨停，贝瑞基因、康辰药业、昭衍新药、奥赛康等多股涨停，三元基因、义翘神州涨超10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11134,202609303887817031.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11134,202609303887817031.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["BK1161","BK0239","06978","BK1574","688185","MEDX","IBBQ","159992","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671220347","title":"节前收红！这个强势板块节后能否继续上涨？","url":"https://stock-news.laohu8.com/highlight/detail?id=2671220347","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671220347?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 18:18","pubTimestamp":1790763480,"startTime":"0","endTime":"0","summary":"医药股强势领涨9月29日，房地产板块大涨4.46%，领涨31个申万大类行业。9月30日，创新药产业链领涨A股，CRO、抗癌药物、创新药、多肽药、血液制品、疫苗等排队站在了概念板块涨幅榜的前列（见图2）。同日，和黄医药宣布，合作方阿斯利康已向美国 FDA 提交赛沃替尼联合奥希替尼的新药上市申请。海思科上半年确认2.65亿美元首付款，净利润同比增427%；荣昌生物确认艾伯维6.5亿美元首付款，营收同比增433%，扭亏为盈。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2026-09-30/doc-initrfsz1964363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBBQ","LNGR","MEDX","BK1161","BK1574","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671270080","title":"节前最后一天，医药股大爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=2671270080","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671270080?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 17:47","pubTimestamp":1790761678,"startTime":"0","endTime":"0","summary":"不是避险那么简单","market":"sh","thumbnail":"https://img3.gelonghui.com/50a7b-01410ab2-9316-4435-996e-69e47fb62888.jpg?guru_height=1632&guru_width=2912&guru_size=805984","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/50a7b-01410ab2-9316-4435-996e-69e47fb62888.jpg?guru_height=1632&guru_width=2912&guru_size=805984"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6865350","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1161","BK1574","09939","159938","BK1515"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":9,"totalSize":230,"code":"91000000","status":"200"}]}}